May 26, 2025

Waters Corporation (WAT) Stock Analysis: Exploring a 12% Upside Potential Amid Strong Analyst Support

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is currently making waves with its analytical workflow..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Healthcare Distribution with Strategic Insights

Henry Schein, Inc. (HSIC), a prominent player in the healthcare sector, operates within the medical distribution industry. With a robust market capitalization of $8.96 billion, the..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating a 1.83% Potential Upside

Medpace Holdings, Inc. (NASDAQ: MEDP) is a noteworthy player within the healthcare sector, specializing in diagnostics and research. With a market capitalization of $8.48 billion, Medpace..

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating a 24% Upside in the Biotech Sector

Blueprint Medicines Corporation (NASDAQ: BPMC), a prominent player in the biotechnology sector, is making waves with its promising pipeline of precision therapies designed to target genomically..

STERIS plc (STE) Stock Analysis: 8.28% Potential Upside in the Healthcare Sector

STERIS plc (NYSE: STE) stands out as a compelling investment opportunity in the healthcare sector, particularly for those eyeing the medical devices industry. With a market..

Avantor, Inc. (AVTR) Stock Analysis: Exploring a 33.84% Upside Potential in the Healthcare Sector

Avantor, Inc. (AVTR), a key player in the healthcare sector, is capturing investor attention with its significant potential upside of 33.84%, as indicated by analyst target..

Novo Nordisk A/S (NVO) Investor Outlook: Exploring a 35.67% Potential Upside

Novo Nordisk A/S (NYSE: NVO), a stalwart in the healthcare sector, is a leading name in the drug manufacturing industry, particularly excelling in diabetes and obesity..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A 58% Upside Potential in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has captured the attention of investors with its promising outlook in the biotechnology industry. Specializing in novel therapeutics for metabolic dysfunction-associated..

DaVita Inc. (DVA) Stock Analysis: Evaluating a 17.96% Potential Upside in the Dialysis Market

DaVita Inc. (NYSE: DVA) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Denver, Colorado, DaVita specializes..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unlocking a 66.65% Potential Upside in the Biotech Sector

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a significant player in the biotechnology sector, with a focus on developing therapies for rare and life-threatening diseases. Based..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: A 42% Upside in the Healthcare Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a key player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity for those keeping a keen..

Masimo Corporation (MASI) Stock Analysis: Unveiling a 21% Potential Upside in the Medical Devices Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the medical devices industry, is drawing attention from investors with a compelling 21.28% potential upside based on current..

Revvity, Inc. (RVTY) Stock Analysis: A 39.75% Upside Signals Promising Potential for Investors

Revvity, Inc. (NYSE: RVTY) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $10.53 billion, this..

Amgen Inc. (AMGN) Stock Analysis: Strong Free Cash Flow and 15.66% Potential Upside

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, stands out with a robust market presence among drug manufacturers. With a market capitalization of $146.07..

Insulet Corporation (PODD) Stock Analysis: A Healthcare Powerhouse with Robust Growth and Investor Confidence

Insulet Corporation (NASDAQ: PODD) stands out as a formidable player in the medical devices sector, making significant strides in insulin delivery systems. With a market capitalization..

Illumina, Inc. (ILMN) Investor Outlook: Assessing a 32.55% Upside Potential

Illumina, Inc. (NASDAQ: ILMN), a titan in the diagnostics and research industry, commands a significant presence in the healthcare sector with its cutting-edge sequencing and array-based..

argenx SE (ARGX) Stock Analysis: Exploring a Biotech Powerhouse with Robust Growth and Significant Upside Potential

argenx SE (NASDAQ: ARGX) stands out in the biotechnology sector, not just for its innovative therapies but also for its impressive financial trajectory and potential market..

Biogen Inc. (BIIB) Stock Analysis: Navigating a 36.67% Potential Upside in the Healthcare Sector

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, commands attention from investors with a market capitalization of $18.43 billion. The company is renowned for..

ICON plc (ICLR) Stock Analysis: Exploring a 37.85% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR) stands as a formidable entity in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Dublin, Ireland, this clinical..

Qiagen N.V. (QGEN) Investor Outlook: Unpacking a 16.99% Potential Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector should pay close attention to Qiagen N.V. (NYSE: QGEN), a leading player in diagnostics and research based in the..

Search

Funds

May 26, 2025

Search

Funds

May 26, 2025

FTSE 100

Funds